The U.S. Food and Drug Administration has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.
If you’re new here, you may want to subscribe to our RSS feed. Thanks for visiting!